It is critical that we rightsize and redistribute available funds based on our knowledge of persistent cancer disparities to help more patients benefit from potentially lifesaving innovations and ensure no one is left behind.
Access to oncology-specific interdisciplinary care delivered digitally by a team of nurses, mental health therapists, nutritionists, advanced practice providers, and oncologists is the best option for combatting pain points related to both cost and access.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Immune checkpoint inhibitors are effective cancer treatments, but are expensive. Understanding the least-costly settings for administering treatments, leveraging genomic testing and following evidence-based guidelines can help health plans optimize cancer care, according to Evernorth Research Institute.
Carrum Health's $45 million funding round was led by OMERS Growth Equity and included participation from Revelation Partners, Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. It brings the company’s total financing to about $96 million.
Although conversations around other LGBTQ+ issues are prevalent in mainstream culture, more work needs to be done on understanding our screening, treatment, and survivorship.
Blue Cross and Blue Shield of Minnesota formed a value-based arrangement with Minnesota Oncology in 2019. Preliminary data show that it led to a reduction in the total cost of care, emergency visits and inpatient admissions.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
If the medical field wants to make serious progress on the Cancer Moonshot effort, it must expand its definition of personalized medicine and explore fresh approaches to cancer prevention, according to Dr. Siddhartha Mukherjee, a Pulitzer Prize-winning author and cancer physician at Columbia University Medical Center.
In response to emailed questions, executives from Biofourmis, Force Therapeutics and Project Ronin shared products they're developing in remote patient monitoring as part of the broader hospital at home trend.
As they seek to support their staff, self-insured employers are turning to innovative programs to balance evidence-based programs with the need to manage healthcare costs.
For data to be truly valuable, it must take into consideration all the facets of the patient’s life. That will allow researchers to uncover new patterns in cancer prognosis, diagnosis and treatment.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The series A funding round was led by General Catalyst, with Human Capital, W Health Ventures, Redesign Health and 7wireVentures also contributing. The latest fundraising effort brings Jasper’s total funding to approximately $31 million.
The health technology company will use the investment to deploy its cancer care management platform and remote monitoring program at more health systems and to advance its research capabilities. Philips Health Technology Ventures led the equity round, and Cerner was a returning investor.
The New York City-based health system implemented Current Health's remote patient monitoring solution to enhance its cancer care services. Amid the Covid-19 pandemic, cancer care has been severely delayed, and the health system aims to provide more consistent care to this patient group through the new solution.